Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy
Titel:
Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy
Auteur:
Finanger, Erika Vandenborne, Krista Finkel, Richard S. Lee Sweeney, H. Tennekoon, Gihan Yum, Sabrina Mancini, Maria Bista, Pradeep Nichols, Andrew Liu, Hanlan Fretzen, Angelika Donovan, Joanne M.